KLRK1 and neoplasm: Peripheral blood NK cells, in pancreatic ductal adenocarcinoma (PDAC) patients, display CD16 and CD57 upregulation, while these markers are downregulated in the scanty NK cells infiltrating the tumor, showing also reduced NKG2D and NKp30 activating receptors expression [178].